Alternatives to Drug Discovery AI

Data-driven drug discovery and development company using machine learning and high-throughput biology.

Atomwise uses AI to accelerate the discovery of novel small molecule therapeutics with its AtomNet platform.

AI platform for accelerating novel peptide therapeutic discovery and development.

AI-powered drug discovery platform leveraging nature's chemistry for novel therapeutics.

AI-driven drug discovery platform for rapid development of novel therapeutics.

AI-driven drug discovery company developing novel medicines for unmet patient needs.

A clinical-stage AI drug discovery company accelerating the development of novel therapeutics for various diseases.

AI-powered drug discovery and development platform for biologics.

Selitectix develops AI-powered solutions for drug discovery, focusing on accelerating the identification and optimization of novel therapeutic candidates.

AI-powered biotechnology company developing RNA therapeutics for genetic diseases.

Oncometra is developing an AI-powered platform to accelerate drug discovery and development for oncology.

AI platform for drug discovery and development, optimizing targets, compounds, and combination therapies.

Biotechnology company specializing in antibody discovery and development with integrated 'Idea to IND' solutions.

Vivodyne is developing advanced AI models for drug discovery and development.

AI-powered drug discovery platform for accelerated molecular design.

AI-powered platform for designing novel molecular structures for new medicines.

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.